Pathologists whose laboratory work led to treatments and to the study of disease causes: Florey with penicillin, Domagk with the first sulfonamide drug and Himsworth with the insulin insensitivity of diabetes. A person belongs here when the cited article describes a pathologist or medical researcher whose bench work produced a drug or a disease concept. It excludes the descriptive pathologists. The three share a hospital laboratory origin, and a later pathologist whose bench work produced a treatment would be admitted by the same test.
Browse By
Experimental Pathologists and Chemotherapy Pioneers
Filter Results3 entries
Sources
Edwin Goldmann (source article)
Has Member: Edwin Goldmann, Section Discovery of the blood-brain barrierQuote, Has Member: Edwin Goldmann, Section Discovery of the blood-brain barrier
Goldmann's mentor, Paul Ehrlich, was studying staining in his bacteriological studies
Gerhard Domagk (Wikipedia)
Has Member: Gerhard Domagk, Introduction, sentences 1-2Quote, Has Member: Gerhard Domagk, Introduction, sentences 1-2
Gerhard Johannes Paul Domagk (German pronunciation: [ˈɡeːɐ̯haʁt ˈdoːmak] ; 30 October 1895-24 April 1964) was a German pathologist and bacteriologist. He is credited with the discovery of sulfonamidochrysoidine (KL730) as an antibiotic for which he received the 1939 Nobel Prize in Physiology or Medicine.
Howard Florey (Wikipedia)
WikipediaHas Member: Howard Florey, Introduction, sentence 1Quote, Has Member: Howard Florey, Introduction, sentence 1
Howard Walter Florey, Baron Florey of Adelaide and Marston (; 24 September 1898-21 February 1968) was an Australian pharmacologist and pathologist who shared the Nobel Prize in Physiology or Medicine in 1945 with Ernst Chain and Sir Alexander Fleming "for the discovery of penicillin and its curative effect in various infectious diseases".
Reader Challenges (0)
No disputes yet. Spotted an error or a better source? Open the first one.
Sign in to dispute this or suggest a correction.